Term
Key factor in biological agent delivery |
|
Definition
- particle diameter
- aerosole spray/cloud: 5-17 microns
- 1-5 microns absorbed in alveoli
- greater than 5-10 is filtered out or deposited in URT
|
|
|
Term
What criteria does CDC used to define potential of biologic agents to be used as weapons |
|
Definition
- ease of dissemination
- potential for major public health impact
- requirements for public health preparedness
|
|
|
Term
epidemiologic criteria of bioterrorism outbreak criteria |
|
Definition
- severe disease in a healthy patient
- increased number of patients with fever, rash, respiratory or GI symptoms, or sepsis
- large number of rapidly fatal respiratory cases
- increasing number of ill or dead animals
- rapid rise and fall in epidemic curve
- multiple patients presenting from a similar location
- endemic disease at an unusual time of year
|
|
|
Term
clinical signs of recognizing bioterrorism outbreak |
|
Definition
- severe gastroenteritis
- fatal pneumonia in healthy patient
- widened mediastinum with fever
- rash with synchronous vesicular/pustular lesions
- acute neurologic illness with fever
- advancing CN palsy with weakness
|
|
|
Term
CDC category A agents criteria |
|
Definition
- easily disseminated/transmitted
- high mortality rates
- potential for major public health impact
- potential for public panic and social disruption
- special action for public health preparedness
- greatest risk agents
|
|
|
Term
Name some CDC category A agents |
|
Definition
- anthrax
- plague
- smallpox
- tularemia
- VHF's
- botulism
- ricin
|
|
|
Term
anthrax: symptoms, causative agent, epidemiology |
|
Definition
- Bacillus antracis
- spore forming gram positive bacteria
- epidemiology
- zoonotic disease of herbivores
- occurs naturally in humans handling contaminated animal products
- transmission- skin abrasion, inhalation, consume infected meat
- cause dermatologic, GI, and inhalation illness
|
|
|
Term
cutaneous anthrax: clinical symptoms, mortality |
|
Definition
- commonly on upper extremities
- papule followed by vesicle
- vesicle dries to form black scab (eschar)
- mortality
- 1% w/tx
- can be systemic w/20% mortality
|
|
|
Term
GI anthrax: symptoms, transmission |
|
Definition
- rare
- transmission- acquired through ingestion of contaminated undercooked meat
- symptoms
- oral/esophageal ulcer can progress to lymphadenopathy and edema
- severe sepsis
|
|
|
Term
Why are anthrax and tularemia of major concern as biological agents |
|
Definition
- greatest spread
- greatest number of fatalities and incapacitation
|
|
|
Term
inhalation anthrax (symptoms, mortality) |
|
Definition
- clinical course
- nonspecific prodrome of fever, SOB, cough, chest discomfort
- brief period of improvement possible
- after 2-4 days, resp failure w/ hemodynamic collapse
- mortality: 50-95%
aka woolsorter's disease |
|
|
Term
|
Definition
- chest X ray
- widened mediastinum
- relative sparing of lung tissue
- can see even: mediastinum, pleural effusion
- gram stain blood, blood culture on routine media or ELISA late
- look for hemorrhagic meningitis
- leukocytosis
|
|
|
Term
|
Definition
- penicillin is tx of choice
- CDC advice initial therapy with doxycycline or ciprofloxacin until sensitivities available
- px w/cipro or doxycycline for at least 60 days in exposed individuals
- close medical surveillance
- licensed vaccine approved by FDA
|
|
|
Term
plague: causative agent, relative mortality, potential mechanism of transmission in bioterrorism |
|
Definition
- causative agent- Yersinia pestis (gram negative rods)
- difficult to weaponize but:
- it would probably be used as aerosol causing pneumonic, not bubonic plague
- very high mortality
|
|
|
Term
Plague: mechanism of transmission and pathogenesis |
|
Definition
- transmission (zoonosis of rodent host and flea vector)
- inhalation of aerosoles (human to human)
- flea bite or direct contact with infected fluids/tissues
- multiplies in lung parenchyma
- spreads to mediastinal lymph nodes and bloodstream
- lymphatic infection leads to bubonic form
|
|
|
Term
clinical features of plague |
|
Definition
- severe febrile illness
- headache
- myalgias
- malaise
- chills
- prostration
- GI symptoms
|
|
|
Term
bubonic plague: clinical course, mortality |
|
Definition
- clinical course
- inguinal, axillary, and cervical lymphadenopathy
- tender non fluctuant lymph nodes
- 2-6 dys incubation
- fatality rate for untreated cases is 50%
|
|
|
Term
pneumonic plague (clinical course, dx, secondary to what) |
|
Definition
- secondary to septicemic plague or inhalation of infectious droplets
- clinical course
- incubate 1-3 dys
- fever, productive cough, hemoptysis, chest pain
|
|
|
Term
|
Definition
- chest xray: bilateral infiltrates or lobar consolidation
- gram stain of sputum and lymph node aspirates
- Wright/Giemsa stain shows "safety pin" pattern
- cultures- fried egg appearance after 48-72 hrs
|
|
|
Term
|
Definition
- IM streptomycin
- buboes resolve after 10-14 dys
- chloramphenicol for meningitis
- tx mildly ill pts with doxycyclin
- unprotected direct contacts should get post exposure px with doxycycline BID for 6 days
|
|
|
Term
|
Definition
- clinical presentation occurs 12-72 hrs after exposure
- bulbar symptoms
- diplopia
- dysarthria
- dysphagia
- severe descending paralysis
- respiratory failure may ensue
|
|
|
Term
botulism (causative agent, transmission as bioterrorist agent) |
|
Definition
- causative agent- Clostridium botulinum
- spore forming
- anaerobic bacillus
- transmit as bioterrorist agent via food and air
|
|
|
Term
|
Definition
- antitoxin to prevent progession or shorten illness course
- no indication of px antitoxin
- supportive care
- no benefit of antibiotics
|
|
|
Term
small pox (viral classification) |
|
Definition
|
|
Term
How could small pox be used as a bioweapon |
|
Definition
- no natural reservoir but
- great ease of production and aerosolization (10-100 particles needed for infection)
- virus does exist outside certain laboratories and could be used to cause bioterrorism
|
|
|
Term
smallpox: different clinical syndromes/ classifications |
|
Definition
- variola major (most common)
- variola minor- milder and less than 1% mortality (dx base on assessment of outbreak)
- hemorragic and malignant smallpox- early hemorrhagic form 100% fatal
incubation 12-14 days during which no viral shedding occurs and patient is not contagious |
|
|
Term
small pox: clinical features |
|
Definition
- flu like symptoms
- after 2-3 days characteristic rash in centrifugal distribution
- mucous membrane lesions
- papules to macules to vesicles
- scabbing after 8-14 days
|
|
|
Term
small pox: differential dx |
|
Definition
- severe varicella
- human monkeypox
- patients have lymphadenopathy
- not easily transmitted human to human
- erythema multiforme
- measles
- molloscum contagiosum in HIV patients
|
|
|
Term
|
Definition
- vaccine up to 96 hrs post exposure and prior to appearance of rash can prevent disease severity
- no effective tx
- supportive care
|
|
|
Term
smallpox vaccination policy |
|
Definition
- disease does not spread rapidly (requires close contact)
- retains immunity up to ten yrs
- vaccinate close contacts and patient isolation may contain the outbreak
- since vaccine stopped in 1980, our current population is not immune
|
|
|
Term
smallpox vacinnation complications |
|
Definition
- eczema vaccinatum- erruption at site of eczema that spread to healthy skin
- progressive vaccinia- in immune deficient patients, failure of local lesion to heal, spread of secondary lesions, death
- generalized vaccinia- healthy patients, good progrnosis
- postvaccinial encephalitis- high mortality
- adverse cardiac events
- myocarditis rate increased
- no causal association for cardiac ischemic events after vaccination
|
|
|
Term
smallpox vaccination: response of the body |
|
Definition
- 3-5 days: papule
- 5-8 days: vesicle
- 14-21 days: scab
- formation of papule, vesicle, ulcer, or crusted lesion surrounded by induration indicates successful "take"
|
|
|
Term
What is the risk of ginving smallpox vaccination now |
|
Definition
increased risk due to increased prevalance of immunosuppresion and allergies in population |
|
|
Term
tularemia (causative agent, transmission as bioterrorism agent) |
|
Definition
- Francisella tularensis- small gram negative coccobacillus
- transmission- resp. exposure via aerosol cause typhoidal and pneumonic tularemia
aka rabbit fever |
|
|
Term
clinical course of tularemia |
|
Definition
- 1-21 day incubation
- nonspecific acute febrile illness
- forms
- typhoidal
- ulceroglandular
- glandular
- oculogladular
- orapharyngeal
- pneumonic
|
|
|
Term
Most common form of tularemia, its method of transmission, and clinical symptoms |
|
Definition
- ulceroglandular form
- inoculation of skin or mucous membrane by blood of body fluids of infected animals
- fever, chills, headache, malaise, ulcerated skin lesion, painful regional lymph node inflammation
|
|
|